“I am very impressed with the thoroughness of the analysis. I hope to steer more data your way soon. Again, thank you for undertaking this at a small cost. It is much appreciated.”
“Thanks for getting this back so quickly, and for the thoroughness of the design and report. We look forward to working with you again!”
“We are impressed with Visikol’s reputation, resources, and expertise”
“A pleasure to work with. Concise and detailed report for our 3D cell assay. We’ll have more projects your way soon!”
“Extremely impressive work, thanks for getting this back to us so quickly. I really appreciate the detailed analysis.”
Spotlight
Antibody Penetration Assessment
We leverage advanced 3D cell culture models and our proprietary image analysis techniques to assess how biologics penetrate into solid tumors.
Biomarker Co-localization and Quantification
We perform quantitative analysis of distribution, colocalization and spatial relationships of biomarkers and cells detected in H&E, IF, multiplex IHC and ISH slides.
Tissue Analysis for Immuno-oncology
Automated analysis of the number, distribution, and infiltration of immune cell sub-types within tumor tissue specimens.
Featured Posts
Human Pancreas 3D Tissue Imaging Using Visikol HISTO
Whenever possible, we try to highlight the great work that our customers are doing in using our tissue clearing reagents and kits to image tissues in 3D. Recently, researchers at the University of Florida [...]
Visikol at Society of Toxicology Booth #663
This year marks Visikol's fifth year attending SOT as an exhibitor and the focus for the company this year will be on its 3D cell culture assays for modeling toxicity as well as organ [...]
Visikol Expands Headquarters in Move to Hampton, NJ
To kick off the new year, Visikol has announced that it has expanded its footprint in New Jersey by moving its headquarters to a 6,400 square-foot space in Hampton, NJ with room to grow. [...]
Detecting Tumor Regions Using Convolutional Neural Networks
Breast cancer is a serious disease with a wide array of treatment options depending on the severity of the cancer and other critical aspects. One of these critical aspects is metastasis (spread of the [...]
Barriers to Adopting Machine Learning and Digital Pathology in the Clinic
As a leading provider of digital pathology services and solutions, we have worked with dozens of pharmaceutical companies in helping them transform their qualitative human-driven histopathology workflows into quantitative computer-based applications. While much of [...]
Blog Post: Pre-clinical Ophthalmology Services
Visikol is a contract research organization that provides researchers at academic institutions and pharmaceutical companies with unique services in pre-clinical ophthalmic R&D, which enables identification of the most effective therapeutics and therapeutic targets in [...]
